Skip to main content
Toggle main menu visibility
Menu
Join
Sign In
Communities
Membership
Events
Publications
Learning & Careers
AIChE Home
About
Contact AIChE
Leadership
Events
Communities
Membership
Learning & Careers
Publications
Careers at AIChE
Equity, Diversity, Inclusion
Giving
Students
Young Professionals
Operating councils
Local Sections
Committees
Awards
Communities
Membership
Events
Publications
Learning & Careers
Toggle site search visibility
Sign In
Join
Breadcrumb
Home
Publications
Proceedings
2017 Metabolic Engineering Summit
General Submissions
ME as an Enabling Technology for Driving Innovation
Impact of yeast lipid pathway engineering and bioprocess strategy on cellular physiology and lipid content
2011 Annual Meeting
Session: Round Table Invited Session On QbD: QbD Filings
Chair
Seymour, C.
, Pfizer
Co-Chair
Wu, H.
, FDA
Presentations
03:15 PM
(407a) Progress In Quality by Design Implementation In Fda's Office of New Drug Quality Assessment
03:30 PM
(407b) QbD Approaches for Continuous Manufacturing
03:45 PM
(407c) Experiences with Quality by Design Filings and Prior Approval Inspections
04:00 PM
(407d) Quality by Design for Generic Drugs
04:15 PM
(407e) To Be Updated
04:30 PM
(407f) QUALITY by Design (QBD), Biopharmaceutical Manufacture
04:45 PM
Panel Discussion: Christine Seymour and Huiquan Wu
